Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Myo5aem1/Cya
Common Name:
Myo5a-KO
Product ID:
S-KO-17100
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Myo5a-KO
Strain ID
KOCMP-17918-Myo5a-B6J-VA
Gene Name
Myo5a
Product ID
S-KO-17100
Gene Alias
9630007J19Rik; Dbv; MVa; Myo5; MyoVA; Sev-1; d; d-120J; flail; flr
Background
C57BL/6JCya
NCBI ID
17918
Modification
Conventional knockout
Chromosome
9
Phenotype
MGI:105976
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Myo5aem1/Cya mice (Catalog S-KO-17100) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000123128
NCBI RefSeq
NM_010864
Target Region
Exon 3
Size of Effective Region
~0.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Myo5a, encoding myosin VA, is a key protein involved in intracellular transport processes. It plays a crucial role in melanosome transport, which is essential for pigmentation in various organisms [4,5]. Myosin VA is also likely involved in other cellular trafficking events, affecting a range of biological functions.

In head and neck squamous carcinoma (HNSC), Myo5a is overexpressed, promoting cell migration in vitro, potentially through vimentin regulation. High Myo5a-expressing HNSC shows low tumor-infiltrating lymphocytes, suggesting its involvement in immune infiltration processes [1]. In laryngeal squamous cell carcinoma, overexpression of serum Myo5a predicts cervical nodal occult metastasis and poor prognosis, and miR-145 can inhibit Myo5a to suppress cancer cell proliferation and invasion [7]. In esophageal squamous cell carcinoma, circFNDC3B promotes cancer progression by targeting Myo5a via miR-370-3p/miR-136-5p [8]. In melanoma, a novel MYO5A-BRAF fusion was reported in a fatal case [3], and in pediatric low-grade glioma, a MYO5A::FGFR1 fusion was found [2]. Also, a MYO5A-NTRK3 fusion was detected in a case of central nervous system ganglioneuroblastoma [6]. In mice, novel mutations in Myo5a cause a dilute coat color phenotype due to deficient melanosome transport [4], and in a miniature Dachshund, a frameshift variant in Myo5a led to coat color dilution and neurological defects similar to human Griscelli Syndrome Type 1 [5].

In conclusion, Myo5a is crucial for pigment-related biological functions, as shown by studies in mice and dogs. In cancer research, its involvement in multiple types of carcinomas, such as head and neck, laryngeal, and esophageal squamous cell carcinomas, and its role in fusion events in melanoma, glioma, and ganglioneuroblastoma, provides insights into cancer-related biological processes. These findings from various research models, including gene-associated phenotype studies in animals, contribute to understanding Myo5a's function in normal and disease-related conditions.

References:

1. Xing, Juanli, Gu, Yanan, Song, Yichen, Ma, Junchi, Sui, Fang. 2023. MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma. In BMC cancer, 23, 1267. doi:10.1186/s12885-023-11759-5. https://pubmed.ncbi.nlm.nih.gov/38129784/

2. Galvin, Robert T, Zheng, Cynthia, Fitzpatrick, Garrett, Chen, Liam, Moertel, Christopher L. 2023. MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma. In Neuro-oncology advances, 5, vdad017. doi:10.1093/noajnl/vdad017. https://pubmed.ncbi.nlm.nih.gov/37025756/

3. Clark, Hannah E, Huang, Yuan Yu Michael, Vance, Gail H, Alomari, Ahmed K. 2022. Fatal melanoma with a novel MYO5A-BRAF fusion and small associated conventional nevus: A case report and review of literature. In Journal of cutaneous pathology, 49, 808-812. doi:10.1111/cup.14263. https://pubmed.ncbi.nlm.nih.gov/35596628/

4. Zhang, Hui, Wu, Zhongping, Yang, Lijuan, Chen, Hao, Ren, Jun. . Novel mutations in the Myo5a gene cause a dilute coat color phenotype in mice. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21261. doi:10.1096/fj.201903141RR. https://pubmed.ncbi.nlm.nih.gov/33715225/

5. Christen, Matthias, de le Roi, Madeleine, Jagannathan, Vidhya, Becker, Kathrin, Leeb, Tosso. 2021. MYO5A Frameshift Variant in a Miniature Dachshund with Coat Color Dilution and Neurological Defects Resembling Human Griscelli Syndrome Type 1. In Genes, 12, . doi:10.3390/genes12101479. https://pubmed.ncbi.nlm.nih.gov/34680875/

6. Ito, Jumpei, Nakano, Yoshiko, Shima, Haruko, Ichimura, Koichi, Shimada, Hiroyuki. 2020. Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. In Brain tumor pathology, 37, 105-110. doi:10.1007/s10014-020-00371-1. https://pubmed.ncbi.nlm.nih.gov/32556925/

7. Zhao, Xudong, Zhang, Wei, Ji, Wenyue. 2018. MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma. In OncoTargets and therapy, 11, 3619-3635. doi:10.2147/OTT.S164597. https://pubmed.ncbi.nlm.nih.gov/29950866/

8. Song, Dan, Ye, Ziqi, Chen, Fangyu, Zhan, Liangliang, Sun, Xinchen. 2023. circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p. In BMC cancer, 23, 821. doi:10.1186/s12885-023-11314-2. https://pubmed.ncbi.nlm.nih.gov/37667251/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest